EQ vs EW · rev $41.1M vs P/E 47, rev $1.39B
Equillium Inc (EQ) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Equillium Inc (EQ) is a biotechnology company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported EQ revenue for 2024-12-31 was $41.1M. Net income was -$8.1M. Revenue was up 13.9% from 2023-12-31 to 2024-12-31. EQ currently screens at market cap $189.0M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
EQ currently screens at market cap $189.0M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the EQ and EW stock pages for the full models.
Not investment advice.